NYSE Euronext Announces Trading Volumes for October 2012

  NYSE Euronext Announces Trading Volumes for October 2012

 October 2012 Volumes Impacted by Market Closure in U.S.; Continued Low Level
                                of Volatility

#1 U.S. Equity Options Platform with Record 29% Market Share; NYSE Amex Record
                                    of 18%

Business Wire

NEW YORK -- November 13, 2012

NYSE Euronext (NYX) today announced trading volumes for its global derivatives
and cash equities exchanges for October 2012^1. The industry decision to close
the U.S. markets for two trading days due to Hurricane Sandy resulted in a 9%
decrease in the number of trading days in October 2012 for NYSE Euronext’s
U.S. cash equity and equity options markets. The closure of these markets also
impacted trading on NYSE Euronext’s European derivatives and European cash
trading venues, which remained open. European derivatives and European cash
average daily trading volumes declined 44% and 41%, respectively, during the
closure of the U.S. markets with some residual impact after the markets
reopened. October 2011 trading volumes benefited from higher levels of market
volatility driven by the sovereign debt crisis in Europe and the debt ceiling
issue in the U.S.

Highlights

  *NYSE Euronext global derivatives ADV in October 2012 of 7.2 million
    contracts decreased 11.8% compared to October 2011 and decreased 5.7% from
    September 2012 levels.
  *NYSE Euronext European derivatives products ADV in October 2012 of 3.1
    million contracts decreased 8.0% compared to October 2011 and decreased
    9.1% from September 2012.
  *NYSE Euronext U.S. equity options ADV of 4.0 million contracts in October
    2012 decreased 13.7% compared to October 2011 level and decreased 2.0%
    from September 2012. NYSE Euronext’s U.S. options exchanges accounted for
    28.5% of total U.S. consolidated equity options trading in October 2012, a
    new market share record high, up from 27.3% in October 2011 and up from
    26.0% in September 2012. NYSE Amex equity options registered record market
    share of 17.6%, up from 15.6% in October 2011 and up from 14.6% in
    September 2012.
  *NYSE Liffe U.S. ADV of approximately 43,700 contracts decreased 54.3% from
    95,600 contracts in October 2011, and decreased 47.8% from 83,700
    contracts in September 2012.
  *NYSE Euronext European cash products ADV of 1.3 million transactions in
    October 2012 decreased 26.6% compared to October 2011 and decreased 10.3%
    from September 2012 levels.
  *NYSE Euronext U.S. cash products handled ADV of 1.5 billion shares in
    October 2012 decreased 38.5% compared to October 2011 and decreased 8.0%
    compared to September 2012. NYSE Euronext’s Tape A matched market share in
    October 2012 was 30.6%, down from 33.9% in October 2011 and down from
    31.1% in September 2012.

Derivatives Trading

European Derivatives

  *NYSE Euronext European derivatives products ADV in October 2012 of 3.1
    million contracts decreased 8.0% compared to October 2011 and decreased
    9.1% from September 2012 levels.
  *The 3.1 million in European derivatives futures and options contracts ADV
    in October 2012 consisted of 2.3 million contracts executed through our
    full-service LIFFE CONNECT trading platform and 0.8 million contracts, or
    26.8%, executed through Bclear, NYSE Liffe's trade administration and
    clearing service for OTC products.
  *Year-to-date, European derivatives products ADV of 3.7 million contracts
    was 19.7% below prior year levels. The 3.7 million in futures and options
    contracts ADV year-to-date consisted of 2.7 million contracts executed
    through LIFFE CONNECT trading platform and 1.1 million contracts, or
    28.3%, executed through Bclear.
  *Total fixed income products ADV of 1.5 million contracts in October 2012
    decreased 19.9% from October 2011 and decreased 23.8% from September 2012.
    Year-to-date, total fixed income products ADV of 1.8 million contracts was
    24.0% below prior year levels.
  *Total equity products (including Bclear) ADV of 1.5 million contracts in
    October 2012 increased 5.4% compared to October 2011, and increased 10.9%
    from September 2012. The 1.5 million contracts in equity products ADV in
    October 2012 consisted of 1.1 million contracts in individual equity
    products ADV and 0.4 million contracts in equity index products ADV. The
    1.1 million contracts in individual equity products ADV consisted of 0.7
    million in futures contracts, which represented a 98.5% increase compared
    to October 2011 and 0.4 million in options contracts, which represented a
    27.6% decrease compared to October 2011. Year-to-date, total equity
    products ADV of 1.8 million contracts was 16.0% below prior year levels.
  *Total commodities products ADV of approximately 106,000 contracts in
    October 2012 increased 32.9% compared to October 2011 and increased 12.6%
    compared to September 2012. Year-to-date, total commodities product ADV of
    89,000 contracts was 6.8% above prior year levels.

U.S. Derivatives

  *NYSE Euronext U.S. equity options ADV of 4.0 million contracts in October
    2012 decreased 13.7% compared to October 2011 and decreased 2.0% compared
    to September 2012. Year-to-date, U.S. equity options ADV of 3.9 million
    contracts was 13.3% below prior year levels.
  *Total U.S. consolidated equity options ADV decreased 17.2% to 14.2 million
    contracts in October 2012 compared to October 2011 and decreased 10.5%
    compared to September 2012. Year-to-date, U.S. consolidated equity options
    ADV of 14.8 million contracts was 13.9% below prior year levels.
  *NYSE Euronext’s U.S. options exchanges accounted for 28.5% of total U.S.
    consolidated equity options trading in October 2012, a new market share
    record high, up from 27.3% in October 2011 and up from 26.0% in September
    2012. NYSE Amex equity options registered record market share of 17.6%, up
    from 15.6% in October 2011 and up from 14.6% in September 2012.
  *NYSE Liffe U.S. ADV of approximately 43,700 contracts decreased 54.3% from
    95,600 contracts in October 2011, and decreased 47.8% from 83,700
    contracts in September 2012. Year-to-date, U.S. futures and futures
    options ADV of 74,900 contracts was 5.8% below prior year levels.

Cash Trading

European Cash

  *NYSE Euronext European cash products ADV of 1.3 million transactions in
    October 2012 decreased 26.6% compared to October 2011 and decreased 10.3%
    compared to September 2012. Year-to-date, European cash products ADV of
    1.5 million transactions was 14.0% below prior year levels.

U.S. Cash

  *NYSE Euronext U.S. cash products handled ADV in October 2012 decreased
    38.5% to 1.5 billion shares compared to October 2011 and decreased 8.0%
    from September 2012.
  *Year-to-date, U.S. cash products handled ADV was 1.7 billion shares, down
    27.2% from prior year levels.
  *NYSE Euronext’s Tape A matched market share in October 2012 was 30.6%,
    down from 33.9% in October 2011 and down slightly from 31.1% in September
    2012.

Exchange Traded Funds

  *NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes
    for Tape B and Tape C) of 190 million shares in October 2012 decreased
    52.6% compared to October 2011 and decreased 4.9% compared to September
    2012.
  *Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 213
    million shares was 35.9% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and
provider of innovative trading technologies. The company's exchanges in Europe
and the United States trade equities, futures, options, fixed-income and
exchange-traded products. With approximately 8,000 listed issues (excluding
European Structured Products), NYSE Euronext's equities markets - the New York
Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca -
represent one-third of the world’s equities trading, the most liquidity of any
global exchange group. NYSE Euronext also operates NYSE Liffe, one of the
leading European derivatives businesses and the world's second-largest
derivatives business by value of trading. The company offers comprehensive
commercial technology, connectivity and market data products and services
through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: http://www.nyx.com.

Disclaimer and Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements include, but
are not limited to, statements concerning NYSE Euronext's plans, objectives,
expectations and intentions and other statements that are not historical or
current facts. Forward-looking statements are based on NYSE Euronext's current
expectations and involve risks and uncertainties that could cause actual
results to differ materially from those expressed or implied in such
forward-looking statements. Factors that could cause NYSE Euronext's results
to differ materially from current expectations include, but are not limited
to: NYSE Euronext's ability to implement its strategic initiatives, economic,
political and market conditions and fluctuations, government and industry
regulation, interest rate risk and U.S. and global competition, and other
factors detailed in NYSE Euronext's 2011 Annual Report on Form 10-K and other
periodic reports filed with the U.S. Securities and Exchange Commission or the
French Autorité des Marchés Financiers. In addition, these statements are
based on a number of assumptions that are subject to change. Accordingly,
actual results may be materially higher or lower than those projected. The
inclusion of such projections herein should not be regarded as a
representation by NYSE Euronext that the projections will prove to be correct.
This press release speaks only as of this date. NYSE Euronext disclaims any
duty to update the information herein.

^1 All NYSE Euronext derivatives transactions count buy and sell orders
together as a single transaction. NYSE Euronext European equities transactions
count each buy and sell order as separate transactions, NYSE Euronext U.S.
equities transactions count buy and sell orders together as a single
transaction.

                                                                                                                
                                                                                                                           
NYSE Euronext
Monthly Volume Summary
      
                    Average Daily Volume             Total Volume                      Average Daily         Total Volume
                                                                                       Volume
(Unaudited;                                                                                       % Chg                    % Chg
contracts in        Oct-12     Oct-11     % Chg      Oct-12      Oct-11     % Chg      YTD 2012   vs. YTD    YTD 2012      vs. YTD
thousands)                                                                                        2011                     2011
                                                                                                                           
Number of
Trading Days -      23         21                    23          21                    215                   215
European Cash
Number of
Trading Days -      23         21                    23          21                    216                   216
European
Derivatives
Number of
Trading Days -      21         21                    21          21                    209                   209
U.S. Markets
                                                                                                                           
European
Derivatives         3,140      3,415      -8.0  %    72,218      71,706     0.7   %    3,712      -19.7 %    801,861       -18.9 %
Products
of which Bclear     841        508        65.5  %    19,335      10,669     81.2  %    1,050      -9.6  %    226,747       -8.7  %
                                                                                                                           
Total Fixed         1,523      1,901      -19.9 %    35,029      39,917     -12.2 %    1,787      -24.0 %    385,946       -23.3 %
Income Products
                                                                                                                           
Short Term
Interest Rate       1,383      1,758      -21.3 %    31,814      36,918     -13.8 %    1,637      -25.9 %    353,643       -25.2 %
Products
Medium and Long
Term Interest       140        143        -2.1  %    3,215       2,999      7.2   %    150        6.2   %    32,303        7.2   %
Rate Products ^
1
                                                                                                                           
Total Equity        1,511      1,434      5.4   %    34,755      30,117     15.4  %    1,837      -16.0 %    396,720       -15.3 %
Products ^ 2
                                                                                                                           
Individual          1,107      876        26.4  %    25,458      18,391     38.4  %    1,358      -14.9 %    293,299       -14.1 %
Equity Products
Futures             715        360        98.5  %    16,445      7,566      117.4 %    907        -8.8  %    195,847       -7.9  %
Options             392        515        -24.0 %    9,014       10,825     -16.7 %    451        -25.1 %    97,453        -24.4 %
Equity Index        404        558        -27.6 %    9,297       11,727     -20.7 %    479        -19.0 %    103,421       -18.3 %
Products
                                                                                                                           
of which Bclear     841        508        65.5  %    19,335      10,669     81.2  %    1,050      -9.6  %    226,747       -8.7  %
Individual          778        438        77.6  %    17,896      9,202      94.5  %    977        -9.6  %    210,933       -8.7  %
Equity Products
Futures             710        357        98.6  %    16,322      7,505      117.5 %    884        -9.6  %    190,855       -8.8  %
Options             68         81         -15.4 %    1,573       1,697      -7.3  %    93         -8.8  %    20,078        -7.9  %
Equity Index        63         70         -10.4 %    1,439       1,467      -1.9  %    73         -9.5  %    15,814        -8.6  %
Products
                                                                                                                           
Commodity           106        80         32.9  %    2,434       1,672      45.6  %    89         6.8   %    19,195        7.8   %
Products
                                                                                                                           
U.S.
Derivatives
Products
                                                                                                                           
Equity Options
^ 3
                                                                                                                           
NYSE Euronext
Options             4,039      4,678      -13.7 %    84,817      98,242     -13.7 %    3,875      -13.3 %    809,951       -13.7 %
Contracts
Total
Consolidated        14,190     17,147     -17.2 %    297,991     360,081    -17.2 %    14,795     -13.9 %    3,092,072     -14.3 %
Options
Contracts
                                                                                                                           
NYSE Group          28.5   %   27.3   %              28.5    %   27.3    %             26.2   %   0.2   %    26.2      %   0.2   %
Share of Total
                                                                                                                           
NYSE Liffe U.S.
                                                                                                                           
Futures and
Futures Options     43.7       95.6       -54.3 %    1,006       2,008      -49.9 %    74.9       -5.8  %    16,184.0      -5.4  %
Volume*
                                                                                                                           
European Cash
Products            1,279      1,743      -26.6 %    29,421      36,600     -19.6 %    1,507      -14.0 %    323,977       -13.6 %
(trades in
thousands)
                                                                                                                           
Equities            1,233      1,675      -26.4 %    28,364      35,167     -19.3 %    1,457      -13.5 %    313,169       -13.1 %
Exchange-Traded     12         23         -48.4 %    267         473        -43.4 %    14         -34.9 %    2,918         -34.6 %
Funds
Structured          29         41         -30.5 %    656         862        -23.9 %    32         -25.7 %    6,782         -25.4 %
Products
Bonds               6          5          25.2  %    133         97         37.1  %    5          3.2   %    1,109         3.7   %
                                                                                                                           
U.S. Cash
Products            1,536      2,496      -38.5 %    32,251      52,418     -38.5 %    1,710      -27.2 %    357,431       -27.5 %
(shares in
millions) ^ 5
                                                                                                                           
NYSE Listed
(Tape A) Issues
^4
                                                                                                                           
Handled Volume      1,103      1,726      -36.1 %    23,157      36,238     -36.1 %    1,224      -26.0 %    255,801       -26.3 %
^5
Matched Volume      1,052      1,632      -35.6 %    22,083      34,277     -35.6 %    1,161      -25.9 %    242,617       -26.3 %
^6
Total NYSE
Listed              3,439      4,810      -28.5 %    72,216      101,017    -28.5 %    3,712      -17.0 %    775,753       -17.4 %
Consolidated
Volume
                                                                                                                           
Share of Total
Consolidated
Volume
Handled Volume      32.1   %   35.9   %   -3.8  %    32.1    %   35.9    %  -3.8  %    33.0   %   -4.0  %    33.0      %   -4.0  %
^5
Matched Volume      30.6   %   33.9   %   -3.3  %    30.6    %   33.9    %  -3.3  %    31.3   %   -3.8  %    31.3      %   -3.8  %
^6
                                                                                                                           
NYSE Arca, MKT
and Regional
(Tape B) Listed
Issues
                                                                                                                           
Handled Volume      214        454        -52.9 %    4,491       9,528      -52.9 %    251        -35.7 %    52,520        -36.0 %
^5
Matched Volume      198        410        -51.8 %    4,154       8,616      -51.8 %    227        -35.6 %    47,392        -35.9 %
^6
Total NYSE Arca
& MKT Listed        932        1,763      -47.1 %    19,567      37,013     -47.1 %    1,068      -29.2 %    223,216       -29.6 %
Consolidated
Volume
                                                                                                                           
Share of Total
Consolidated
Volume
Handled Volume      23.0   %   25.7   %   -2.7  %    23.0    %   25.7    %  -2.7  %    23.5   %   -2.4  %    23.5      %   -2.4  %
^5
Matched Volume      21.2   %   23.3   %   -2.1  %    21.2    %   23.3    %  -2.1  %    21.2   %   -2.1  %    21.2      %   -2.1  %
^6
                                                                                                                           
Nasdaq Listed
(Tape C) Issues
                                                                                                                           
Handled Volume      219        317        -30.8 %    4,603       6,653      -30.8 %    235        -22.7 %    49,110        -23.1 %
^5
Matched Volume      195        275        -29.2 %    4,094       5,785      -29.2 %    202        -23.0 %    42,161        -23.3 %
^6
Total Nasdaq
Listed              1,747      2,092      -16.5 %    36,692      43,923     -16.5 %    1,752      -15.7 %    366,240       -16.1 %
Consolidated
Volume
                                                                                                                           
Share of Total
Consolidated
Volume
Handled Volume      12.5   %   15.1   %   -2.6  %    12.5    %   15.1    %  -2.6  %    13.4   %   -1.2  %    13.4      %   -1.2  %
^5
Matched Volume      11.2   %   13.2   %   -2.0  %    11.2    %   13.2    %  -2.0  %    11.5   %   -1.1  %    11.5      %   -1.1  %
^6
                                                                                                                           
Exchange-Traded
Funds ^5,7
                                                                                                                           
Handled Volume      205        443        -53.8 %    4,300       9,311      -53.8 %    236        -36.0 %    49,303        -36.3 %
^5
Matched Volume      190        401        -52.6 %    3,990       8,420      -52.6 %    213        -35.9 %    44,443        -36.2 %
^6
Total ETF
Consolidated        903        1,759      -48.7 %    18,961      36,942     -48.7 %    1,032      -28.8 %    215,701       -29.2 %
Volume
                                                                                                                           
Share of Total
Consolidated
Volume
Handled Volume      22.7   %   25.2   %   -2.5  %    22.7    %   25.2    %  -2.5  %    22.9   %   -2.6  %    22.9      %   -2.6  %
^5
Matched Volume      21.0   %   22.8   %   -1.8  %    21.0    %   22.8    %  -1.8  %    20.6   %   -2.3  %    20.6      %   -2.3  %
^6
                                                                                                                           
                                                                                                                           
                                                                                                                           
^1 Data includes currency products.
                
^2 Includes Bclear tradingIncludes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.
                
^3 Includes trading in U.S. equity options contracts, not equity-index options.
                
^4 Includes all volume executed in NYSE Group crossing sessions.
                
^5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed
to and executed at anexternal market center. NYSE Arca routing includes odd-lots.
                
^6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.
                
^7 Data included in previously identified categories.
                
^* ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days.
                
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.
                
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.
                
                

Please follow us at:

Exchanges Blog

Facebook

LinkedIn

Twitter

Contact:

NYSE Euronext
Media:
Amsterdam, +31.20.550.4488
Brussels, +32.2.509.1392
Lisbon, +351.217.900.029
London, +44.20.7379.2789
New York, +1.212.656.2411
Paris, +33.1.49.27.11.33
or
Investor Relations:
New York, +1-212-656-5700
 
Press spacebar to pause and continue. Press esc to stop.